Browsing by Author "Maaji, H.U"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item The role of Pharmacists in optimizing care for schizophrenic patients at a Tertiary Health Facility in Maiduguri, North-Eastern, Nigeria.(Faculty of Pharmacy, University of Maiduguri, 2018) Giwa, A; Yusuf, H; Mohammed, S; Maaji, H.U; Aguye-Abdu, S.N; Dungus, F.M; Suleiman, H.O; Siyaka, LVarious drug treatment options, frequent occurrence of side effects and low antipsychotic medication compliance all give pharmacists an important role to play in the overall successful treatment of patients with schizophrenia. This study was a descriptive cross sectional study carried out in October 2016 that aimed at assessing the extent to which pharmacists were involved in optimizing care for schizophrenic patients at the Federal Neuro Psychiatric Hospital Maiduguri, North-Eastern Nigeria. All pharmacists working at the institution were administered a 18 item validated self-administered questionnaire, with their responses measured on a five point rating scale of: never, rarely, sometimes, most of the times and always. Majority of the pharmacist were positively involved in traditional pharmaceutical duties like determining drug formulary (62.5%) and identification and resolution of drug therapy problems (81.2%). Majority of them were also involved in maintaining a good relationship with schizophrenic patients (68.7%), discussing side effects of their medication (56.2%) and maintaining open and effective means of communication with other health care professionals (81.2%). Conversely, less than half reported positive involvement under the relatively newer roles such as following up patients (37.5%) and documentation of interventions (18.7%). Pharmacists need to be better educated on the importance of their roles in optimizing care for schizophrenic patients. Educational trainings should be organized both by the pharmacists themselves, and at the hospital level in collaboration with other healthcare professionals.Item Validity evidence of adapted hausa version of 8-item Marisky Medication Adherence Scale in patients with hypertension in North Western Nigeria(Bayero University, Kano., 2018) Giwa, A; Labaran, K.S; Mohammed, S; Maiha, B.B; Maaji, H.U; Yusuf, H; Ibrahim, A.WAdherence to antihypertensive medication is the cornerstone for achieving hypertension control. Morisky Medication Adherence Scale (MMAS-8) is one of the most widely used reported medication adherence measures. The aim of this study was to examine the evidence of the validity of adapted Hausa MMAS in assessing adherence among hypertensive patients in North Western Nigeria. In a longitudinal interventional study of individuals with hypertension, self reported adherence to the antihypertensive drug treatment was measured using the Morisky Medication Adherence Scale consistency of the Morisky Medication Adherence Scale-8 with crobanch's alpha factorial validity was assessed by identifying the underlying components using principal component analyses (PCA). A total of 130 individuals completed the study. Cronbach’s alpha was 0.79. Two components were identified. One component comprised six items: stopping medication when hypertension is under control, stopping when feeling hassled about sticking to the prescription. The second component comprised two other items that were all related to forgetfulness. A significant relationship between MMAS and diastolic blood pressure control (t = 2.2; p = .030), (χ2 = 6.6; p = .036) was found. The MMAS sensitivity and specificity, with positive and negative predictive values were 36%, 77%, 64%, and 52% respectively. The results suggest that the adapted Hausa Morisky Medication Adherence Scale-8 is a two-dimensional scale assessing intentional (first component) and unintentional (second component) non-adherence to the antihypertensive drug treatment. The findings of this validation study indicate that the Hausa version of the MMAS is a reliable and valid measure of medication adherence among hypertensive patients in North-western Nigeria.